Puma Biotechnology, Inc. PBYI
10.84 USD +0.62 (+6.02%)
Nov 4, 2026, 1:18 PM EST
10.32 Day range 10.85
4.58 52-week range 11.50
- YTD
- +82.10%
- 1 year
- +121.12%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 228.37M | 230.47M | 235.64M | 228.03M | 253.16M | |
| 170.21M | 166.06M | 172.96M | 172.94M | 189.45M | |
| 37.30M | 30.97M | 32.64M | 23.72M | 1.29M | |
| 31.11M | 30.28M | 21.59M | 2.00K | -29.13M | |
| 0.61 | 0.62 | 0.45 | — | -0.72 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 31.73M | 69.22M | 84.58M | 76.20M | 71.98M | |
| 216.30M | 213.33M | 230.53M | 222.06M | 226.59M | |
| 85.96M | 121.21M | 177.09M | 200.45M | 229.03M | |
| 28.55M | 74.08M | 111.49M | 114.28M | 116.64M | |
| 130.34M | 92.13M | 53.44M | 21.61M | -2.45M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 41.80M | 38.92M | 27.01M | -15.83M | 20.65M | |
| -36.19M | -20.44M | -19.13M | 7.10M | -10.88M | |
| -45.20M | -33.85M | 0 | 12.22M | -31.93M | |
| -71.00K | -56.00K | -140.00K | 0 | 0 | |
| -39.58M | -15.37M | 7.88M | 3.50M | -22.16M |